IQVIA

From Verify.Wiki
Jump to: navigation, search
Iqvia.png
www.iqvia.com
IQVIA
Type Public
Industry Clinical Development and Biopharma
Slogan The Human Data Science Company
Headquarters Danbury, CT and Durham, NC
Key people Dennis Gillings, Founder
Ari Bousbib, Chairman and CEO
Number of employees ~ 55,000
Related Certifications Certificate in Current Pharmacovigilance Regulatory Landscape

IQVIA is a multinational company which is formed through the merger of IMS Health and Quintiles and it was formerly known as QuintilesIMS. It provides integrated information and technology-enabled healthcare services and operates through three segments: Integrated engagement services, research, development and commercial solutions, which enable life sciences companies to innovate with confidence, maximize opportunities, and drive human health outcomes forward. Solutions are powered by the IQVIA CORE™, which combines big data, advanced technology, analytics and extensive industry knowledge. IQVIA is headquartered in Durham, NC, and Danbury CT, with running operations in more than 100 countries and with more than 55,000 employees worldwide. [1][2]

It’s bigger than better clinical trials. Or advances in technologies and analytics. Or faster insights. It’s about exploring a new path to better health outcomes via Human Data Science. It’s about harnessing the power of the IQVIA CORE™ to channel the insights, commercial and scientific depth, and executional expertise that drive maximum value for our customers.By applying data science to the continuous advancement of human science, decisions become more precise. More relevant. Even more creative

They provide solutions that enable life sciences companies to innovate with confidence, maximize opportunities, and, ultimately, drive human health outcomes forward.[3]

It provides actionable solutions by tapping into the power of the IQVIA CORE™:

• Domain Expertise. Institutional knowledge and domain expertise across diseases, geographies and scientific methods

• Advanced Analytics. Faster, more precise decision-making generated by advanced analytics designed for healthcare

• Unparalleled Data. One of the world’s largest curated healthcare data sources with innovative privacy protections

• Transformative Technology. Leading technologies to provide real-time access to operations-critical information

Human Data Science is a new way for life sciences companies to rethink the future of healthcare. By applying data science to the continuous advancement of human science, decisions become more precise. More relevant. Even more creative. To learn more, visit www.IQVIA.com

History

In 1982, Dennis Gillings founded and incorporated Quintiles Transnational in North Carolina.

Quintiles Transnational established Quintiles Pacific Inc. and Quintiles Ireland Ltd. in 1990, and in 1991 Quintiles GmbH was established in Germany and Quintiles Laboratories Ltd. was established in Atlanta, Georgia.

In September 1996, Quintiles purchased Innovex Ltd. of Britain for $747.5 million in stock.

Quintiles went public in 1997 and completed a successful secondary stock offering.

Over 2016 concluding on October 3, Quintiles underwent a $17.6 billion merger with IMS Health becoming QuintilesIMS.

In Dec 2016, it acquired Q2 Metrics Inc a business intelligence company in the healthcare sector.

In November 2017, the company adopted the new name of IQVIA and changed its ticker symbol from Q to IQV. Its shares will continue to trade on the NYSE.

Recent Award

FORTUNE World's Most Admired Companies 2018

Selected as one of the 2018 FORTUNE “World’s Most Admired Companies®," IQVIA ranked #1 Healthcare: Pharmacy and other services.*

*From FORTUNE Magazine, February 1, 2018 ©2018 Time Inc. FORTUNE and The World’s Most Admired Companies are registered trademarks of Time Inc. and are used under license. FORTUNE and Time Inc. are not affiliated with, and do not endorse products or services of, IQVIA.

Top 5 Recent Tweets

DateAuthorComment
April 09, 2021threadreaderapp@BlessingBox4u Hi! here is your unroll: IQVIA, the same ones that helped Pacira gather up the data for the…… https://t.co/ASwM7eIyuy
April 09, 2021ConferenceForumTaking place now: Panel discussion on improving patient engagement at the clinical site level.… https://t.co/j2CC7ze8bh
April 09, 2021novasytehealthWe're hiring! Apply today to join the Novasyte Health team: https://t.co/qIflnltSr2 #novasyte #IQVIAMedTech… https://t.co/rAkQZrkgFB
April 07, 2021IQVIA_InstituteThe new wave of approved and launched #biosimilars, mostly in oncology, are showing faster uptake than older biosim… https://t.co/70leRhFaTg
April 09, 2021AADskinSpringtime means more time outdoors… which can also lead to increased eczema flares. Learn how to identify outdoor… https://t.co/7IqbM3QqfR


Top 5 Recent News Headlines

https://www.linkedin.com/feed/update/urn:li:activity:6417451260252811264 https://www.linkedin.com/feed/update/urn:li:activity:6417436148980813824

https://www.linkedin.com/feed/update/urn:li:activity:6417405975224938496

Top 5 Lifetime Tweets

https://twitter.com/IQVIA_global/status/1011730865557311489

https://twitter.com/IQVIA_global/status/1011715759389716482

https://twitter.com/IQVIA_global/status/1011700673057034241

Top 5 Lifetime News Headlines

References

  1. https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=137473239
  2. https://www.iqvia.com/newsroom/2018/05/prugen-pharmaceuticals-selects-iqvias-oce-technology-platform-to-advance-field-sales-and-home-office
  3. https://www.iqvia.com/about-us

Verification history